What is a mannitol drug and how does it work?
Mannitol is a sugar alcohol that creates an osmotic gradient in the body. It pulls fluid from tissues into the bloodstream, which is useful for lowering intracranial pressure, treating acute glaucoma, and promoting diuresis in renal failure. Its effect is short‑term and requires careful monitoring of electrolytes and fluid status. [1]
Who makes mannitol and is OM Pharma a major supplier?
Mannitol is available as a generic from several manufacturers worldwide. OM Pharma lists a mannitol formulation on its product catalog and holds the rights to the generic name in several markets. While not the largest producer, it competes with other generic makers by offering a cost‑effective option for hospitals and outpatient settings. [2]
When do patents on mannitol expire, and can OM Pharma offer generics?
The original patents for mannitol formulations, filed in the 1970s, have long expired, leaving the active ingredient in the public domain. However, some manufacturers have secured secondary patents for delivery systems (e.g., extended‑release eye drops) that can still be enforced. OM Pharma’s patents focus on these formulation aspects, allowing it to sell branded generic products until the secondary patents lapse. [1]
What are the main uses and dosing guidelines for mannitol?
- Intracranial pressure: 0.5–1.0 g/kg IV over 30 min, repeat every 4–6 h if needed.
- Acute glaucoma: 20–25 mg/mL eye drops, instilled every 2–3 min until pressure normalizes.
- Diuretic: 50–100 mg orally in patients with renal impairment, monitored for electrolyte changes. Dosing must be individualized, and the drug is avoided in severe dehydration or uncontrolled diabetes.
What side effects and safety concerns should patients know?
Common adverse effects include nausea, vomiting, and headaches. More serious risks are fluid overload, electrolyte imbalance, and, rarely, anaphylaxis. Patients on diuretics or with heart failure require close monitoring of weight and blood pressure.
How does mannitol compare with other osmotic agents like glycerol or hypertonic saline?
Mannitol has a faster onset and a predictable diuretic response. Glycerol is slower and may cause more systemic side effects, while hypertonic saline is preferred when a rapid reduction in intracranial pressure is critical but can lead to hypernatremia. Mannitol’s balanced profile makes it the first choice for most neurosurgical and ophthalmic indications.
Can patients switch from brand to OM Pharma mannitol, and what should they watch for?
Switching to a generic OM Pharma product is usually safe because the active ingredient is identical. However, patients should be informed about the specific formulation (e.g., concentration, preservatives) and any potential differences in excipients that could affect tolerability or dosing.
---
Sources
[1] https://www.drugpatentwatch.com/mannitol
[2] https://www.drugpatentwatch.com/om-pharma